News | January 13, 2025
Aragen secures $100 million investment from Quadria Capital
Investment will fund expansion to meet rising demand for CRDMO services
Investment will fund expansion to meet rising demand for CRDMO services
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems
Extended lab space for product development, customer demos, and training
Subscribe To Our Newsletter & Stay Updated
